Schedule 13D ownership disclosure

Sionna Therapeutics Inc

Common Stock · CUSIP: 829401108

Event date: 2025-02-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 3,704,959.00 · Class: 8.4%

  • OrbiMed Capital GP VIII LLCReported CIK 0001845804

    Shares: 3,704,959.00 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-25-000138
Form type
SCHEDULE 13D
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Feb 13, 2025
Reporting period
Feb 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub